Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.025
-0.025 (-1.22%)
At close: Oct 9, 2026, 4:00 PM EDT
1.986
-0.039 (-1.91%)
After-hours: Oct 9, 2026, 5:22 PM EDT

Aytu BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
22232017927
Market Cap Growth
-6.36%17.92%12.22%97.32%-66.79%-78.89%
Enterprise Value
141924161520
Last Close Price
2.022.152.182.921.6013.80

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-9.039.03---
PS Ratio
0.380.400.300.270.120.28
PB Ratio
0.620.651.030.630.230.60
P/FCF Ratio
6.777.10----
P/OCF Ratio
6.717.03----

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
0.240.340.360.250.200.21
EV/EBITDA Ratio
--3.022.245.92-
EV/EBIT Ratio
--9.4328.87--
EV/FCF Ratio
4.245.94----

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.510.511.210.590.470.41
Debt / EBITDA Ratio
--2.681.754.68-
Debt / FCF Ratio
5.575.57----
Net Debt / Equity Ratio
-0.23-0.23-0.42-0.13-0.11-0.03
Net Debt / EBITDA Ratio
1.871.87-1.01-0.49-1.820.04
Net Debt / FCF Ratio
-2.52-2.523.702.090.880.04
Asset Turnover
0.500.500.550.510.540.48
Inventory Turnover
2.272.271.741.562.233.41
Quick Ratio
0.900.900.990.700.750.64
Current Ratio
1.131.131.261.001.030.93
Return on Equity (ROE)
-52.55%-52.55%-60.76%-37.33%-18.05%-119.62%
Return on Assets (ROA)
-4.54%-4.54%1.31%0.28%-2.37%-11.81%
Return on Capital Employed (ROCE)
-16.50%-16.50%4.20%1.00%-7.70%-52.10%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-64.77%-61.76%-69.30%-90.85%-192.92%-408.69%
FCF Yield
14.78%14.09%-11.06%-9.85%-58.03%-108.29%
Buyback Yield / Dilution
-96.17%-96.17%-13.40%-65.81%-127.22%-75.54%
SEC Filings: 10-K · 10-Q